Parasitic Disease
14
2
4
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Microbiome and Malnutrition in Pregnancy
Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria
A Study to Compare Two Dosing Regimens for a New Malaria Vaccine
Microbiome and Malnutrition in Pregnancy (MMiP)
The Impact of Parasitic Infection on Multiple Sclerosis and Nephrotic Syndrome
Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites
Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)
Enterobius Vermicularis Infestation of the Appendix
Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
Parasitic Infections of the Gastrointestinal Tract
The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands